Sign in

CIK 0001604821 · Large accelerated filer

Natera, Inc.

Sign in to watch
Ticker
NTRA
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
010894487
Phone
650-249-9090
Business address
13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
Former names
Natera, Inc.
  1. 144 Insider Sale of Securities
  2. 4 Planned sale PRESIDENT, CLINICALDIAGNOSTICS sold 1,652 shares at $202.84 ($335,091)
  3. 4 Planned sale PRESIDENT, CHIEF BUS. OFFICER sold 1,438 shares at $202.84 ($291,684)
  4. 4 Planned sale Director sold 4,650 shares at an average $206.33 ($959,451)
  5. 10-Q Report Quarterly Report
  6. 8-K Event Results of operations
  7. 4 Planned sale EXECUTIVE CHAIRMAN sold 7,708 shares at an average $213.05 ($1,642,211)
  8. 4 Planned sale CHIEF FINANCIAL OFFICER sold 795 shares at an average $208.79 ($165,984)
  9. 4 Planned sale Director sold 107 shares at $206.16 ($22,059)
  10. 4 Planned sale PRESIDENT, CLINICALDIAGNOSTICS sold 3,405 shares at an average $203.69 ($693,560)
  11. 4 Planned sale PRESIDENT, CHIEF BUS. OFFICER sold 291 shares at $206.16 ($59,993)
  12. 4 Planned sale CEO AND PRESIDENT sold 902 shares at $206.16 ($185,956)
  13. 4 Planned sale SEC. AND CHIEF LEGAL OFFICER sold 330 shares at $206.16 ($68,033)
  14. 144 Insider Sale of Securities
  15. 144 Insider Sale of Securities
  16. SCHEDULE 13G Stake Statement of Beneficial Ownership
  17. 4 Planned sale CHIEF FINANCIAL OFFICER sold 5,063 shares at an average $197.84 ($1,001,645)
  18. 4 Planned sale CEO AND PRESIDENT sold 5,838 shares at an average $204.14 ($1,191,775)
  19. 4 Planned sale PRESIDENT, CHIEF BUS. OFFICER sold 1,688 shares at an average $204.10 ($344,517)
  20. 4 Planned sale PRESIDENT, CLINICALDIAGNOSTICS sold 2,182 shares at an average $204.10 ($445,341)

Page 9 of 94 · 1,862 filings